Skip to main content
SpringerLink
Log in

Islet Cell Transplantation

  • Chapter
  • First Online:
Endocrine Surgery in Children

  • 1333 Accesses

Abstract

For a subset of patients with complicated Type I Diabetes Mellitus (T1DM), islet transplantation has become a well-established treatment modality. Before 2000, fewer than 9% of islet transplant recipient maintained insulin independence for greater than one year. The improvements resulting from the Edmonton Protocol have led to high rates of one-year insulin independence, and together with an international collaboration, propagated the expansion of clinical islet transplantation centers worldwide. In spite of the continued success of clinical islet transplantation, a number of limitations with this therapy remain, including the requirement for lifelong immunosuppression with the associated side effects. While islet transplantation is currently generally reserved for adults with T1DM with severe hypoglycemia or glycemic lability, we herein consider the possibility of its application to the pediatric population, moving this therapy one day from a treatment for some to a potential cure for all.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414–31.

    Article  CAS  PubMed  Google Scholar 

  2. Polonsky KS. The past 200 years in diabetes. New Engl J Med. 2012;367(14):1332–40.

    Article  CAS  PubMed  Google Scholar 

  3. Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA. Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J. 1922;12(3):141–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med. 1993;329(14):977–86.

    Article  Google Scholar 

  5. Keen H. The diabetes control and complications trial (DCCT). Health Trends. 1994;26(2):41–3.

    CAS  PubMed  Google Scholar 

  6. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. New Engl J Med. 2003;348(23):2294–303.

    Article  PubMed  Google Scholar 

  7. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery. 1967;61(6):827–37.

    CAS  PubMed  Google Scholar 

  8. Brogard JM, Vetter T, Blickle JF. Discovery of pancreatic diabetes in Strasbourg. Diabete Metabol. 1992;18(2):104–14.

    CAS  Google Scholar 

  9. Agarwal A, Brayman KL. Update on islet cell transplantation for type 1 diabetes. Semin Intervent Radiol. 2012;29(2):90–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 1967;16(1):35–9.

    Article  CAS  PubMed  Google Scholar 

  11. Misler S. The isolated pancreatic islet as a micro-organ and its transplantation to cure diabetes: celebrating the legacy of Paul Lacy. Islets. 2010;2(4):210–24.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Reckard CR, Ziegler MM, Barker CF. Physiological and immunological consequences of transplanting isolated pancreatic islets. Surgery. 1973;74(1):91–9.

    CAS  PubMed  Google Scholar 

  13. Shapiro AM. A historical perspective on experimental and clinical islet transplantation. Informa Health Care. 2007;1.

    Google Scholar 

  14. Lakey JR, Warnock GL, Shapiro AM, Korbutt GS, Ao Z, Kneteman NM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. 1999;8(3):285–92.

    Article  CAS  PubMed  Google Scholar 

  15. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes. 1989;38(Suppl 1):140–2.

    Article  PubMed  Google Scholar 

  16. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New Engl J Med. 2000;343(4):230–8.

    Article  CAS  PubMed  Google Scholar 

  17. Ryan EA, Bigam D, Shapiro AM. Current indications for pancreas or islet transplant. Diabetes Obes Metab. 2006;8(1):1–7.

    Article  PubMed  Google Scholar 

  18. Scharp DW, Kemp CB, Knight MJ, Ballinger WF, Lacy PE. The use of ficoll in the preparation of viable islets of langerhans from the rat pancreas. Transplantation. 1973;16(6):686–9.

    Article  CAS  PubMed  Google Scholar 

  19. Najarian JS, Sutherland DE, Matas AJ, Steffes MW, Simmons RL, Goetz FC. Human islet transplantation: a preliminary report. Transpl Proc. 1977;9(1):233–6.

    CAS  Google Scholar 

  20. Brendel M HB, Shulz A, Bretzel R. International islet transplant registry report. 1999.1–20.

    Google Scholar 

  21. Benhamou PY, Watt PC, Mullen Y, Ingles S, Watanabe Y, Nomura Y, et al. Human islet isolation in 104 consecutive cases. Factors affecting isolation success. Transplantation. 1994;57(12):1804–10.

    Article  CAS  PubMed  Google Scholar 

  22. Goto M, Eich TM, Felldin M, Foss A, Kallen R, Salmela K, et al. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation. 2004;78(9):1367–75.

    Article  PubMed  Google Scholar 

  23. Ihm SH, Matsumoto I, Sawada T, Nakano M, Zhang HJ, Ansite JD, et al. Effect of donor age on function of isolated human islets. Diabetes. 2006;55(5):1361–8.

    Article  CAS  PubMed  Google Scholar 

  24. Lakey JR, Rajotte RV, Warnock GL, Kneteman NM. Human pancreas preservation prior to islet isolation. Cold ischemic tolerance. Transplantation. 1995;59(5):689–94.

    Article  CAS  PubMed  Google Scholar 

  25. Lakey JR, Warnock GL, Rajotte RV, Suarez-Alamazor ME, Ao Z, Shapiro AM, et al. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation. 1996;61(7):1047–53.

    Article  CAS  PubMed  Google Scholar 

  26. Matsumoto I, Sawada T, Nakano M, Sakai T, Liu B, Ansite JD, et al. Improvement in islet yield from obese donors for human islet transplants. Transplantation. 2004;78(6):880–5.

    Article  PubMed  Google Scholar 

  27. Nano R, Clissi B, Melzi R, Calori G, Maffi P, Antonioli B, et al. Islet isolation for allotransplantation: variables associated with successful islet yield and graft function. Diabetologia. 2005;48(5):906–12.

    Article  CAS  PubMed  Google Scholar 

  28. Zeng Y, Torre MA, Karrison T, Thistlethwaite JR. The correlation between donor characteristics and the success of human islet isolation. Transplantation. 1994;57(6):954–8.

    Article  CAS  PubMed  Google Scholar 

  29. Kin T, Murdoch TB, Shapiro AM, Lakey JR. Estimation of pancreas weight from donor variables. Cell Transplant. 2006;15(2):181–5.

    Article  PubMed  Google Scholar 

  30. Brandhorst H, Brandhorst D, Hering BJ, Federlin K, Bretzel RG. Body mass index of pancreatic donors: a decisive factor for human islet isolation. Exp Clin Endocrinol Diabetes. 1995;103(Suppl 2):23–6.

    PubMed  Google Scholar 

  31. Berney T, Johnson PR. Donor pancreata: evolving approaches to organ allocation for whole pancreas versus islet transplantation. Transplantation. 2010;90(3):238–43.

    Article  PubMed  Google Scholar 

  32. O’Gorman D, Kin T, Murdoch T, Richer B, McGhee-Wilson D, Ryan E, et al. The standardization of pancreatic donors for islet isolation. Transpl Proc. 2005;37(2):1309–10.

    Article  Google Scholar 

  33. de Boer J, De Meester J, Smits JM, Groenewoud AF, Bok A, van der Velde O, et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int. 1999;12(6):447–53.

    Article  PubMed  Google Scholar 

  34. Hering BJ, Matsumoto I, Sawada T, Nakano M, Sakai T, Kandaswamy R, et al. Impact of two-layer pancreas preservation on islet isolation and transplantation. Transplantation. 2002;74(12):1813–6.

    Article  PubMed  Google Scholar 

  35. Benhamou PY, Oberholzer J, Toso C, Kessler L, Penfornis A, Bayle F, et al. Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999–2000). Groupe de Recherche Rhin Rhjne Alpes Geneve pour la transplantation d’Ilots de Langerhans. Diabetologia. 2001;44(7):859–64.

    Article  CAS  PubMed  Google Scholar 

  36. Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, et al. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation. 2002;74(12):1761–6.

    Article  CAS  PubMed  Google Scholar 

  37. Wolters GH, Vos-Scheperkeuter GH, van Deijnen JH, van Schilfgaarde R. An analysis of the role of collagenase and protease in the enzymatic dissociation of the rat pancreas for islet isolation. Diabetologia. 1992;35(8):735–42.

    Article  CAS  PubMed  Google Scholar 

  38. Johnson PR, White SA, London NJ. Collagenase and human islet isolation. Cell Transplant. 1966;15(4):437–52.

    Google Scholar 

  39. Wang X, Meloche M, Verchere CB, Ou D, Mui A, Warnock GL. Improving islet engraftment by gene therapy. J Transplant. 2011;2011:594851.

    PubMed  PubMed Central  Google Scholar 

  40. Mehigan DG, Bell WR, Zuidema GD, Eggleston JC, Cameron JL. Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg. 1980;191(3):287–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Lake SP, Bassett PD, Larkins A, Revell J, Walczak K, Chamberlain J, et al. Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes. 1989;38(Suppl 1):143–5.

    Article  CAS  PubMed  Google Scholar 

  42. Ichii HPA, Khan A, Fraker C, Ricordi C. Culture and transportation of human islets between centers. Islet transplantation and beta cell replacement therapy. New York: Informa healthcare; 2007. p. 251.

    Book  Google Scholar 

  43. Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA. 2005;293(7):830–5.

    Article  CAS  PubMed  Google Scholar 

  44. Gangemi A, Salehi P, Hatipoglu B, Martellotto J, Barbaro B, Kuechle JB, et al. Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant. 2008;8(6):1250–61.

    Article  CAS  PubMed  Google Scholar 

  45. Froud T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure P, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant. 2005;5(8):2037–46.

    Article  PubMed  Google Scholar 

  46. Froud T, Faradji RN, Pileggi A, Messinger S, Baidal DA, Ponte GM, et al. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects. Transplantation. 2008;86(1):36–45.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Ghofaili KA, Fung M, Ao Z, Meloche M, Shapiro RJ, Warnock GL, et al. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Transplantation. 2007;83(1):24–8.

    Article  PubMed  Google Scholar 

  48. Faradji RN, Tharavanij T, Messinger S, Froud T, Pileggi A, Monroy K, et al. Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation. 2008;86(12):1658–65.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Rajab A. Islet transplantation: alternative sites. Curr Diab Rep. 2010;10(5):332–7.

    Article  PubMed  Google Scholar 

  50. Froud T, Yrizarry JM, Alejandro R, Ricordi C. Use of D-STAT to prevent bleeding following percutaneous transhepatic intraportal islet transplantation. Cell Transplant. 2004;13(1):55–9.

    Article  PubMed  Google Scholar 

  51. Barshes NR, Lee TC, Goodpastor SE, Balkrishnan R, Schock AP, Mote A, et al. Transaminitis after pancreatic islet transplantation. J Am Coll Surg. 2005;200(3):353–61.

    Article  PubMed  Google Scholar 

  52. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes. 2002;51(1):66–72.

    Article  CAS  PubMed  Google Scholar 

  53. Owen RJ, Ryan EA, O’Kelly K, Lakey JR, McCarthy MC, Paty BW, et al. Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology. 2003;229(1):165–70.

    Article  PubMed  Google Scholar 

  54. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54(7):2060–9.

    Article  CAS  PubMed  Google Scholar 

  55. Gala-Lopez B, Pepper AR, Shapiro AM. Biologic agents in islet transplantation. Curr Diab Rep. 2013;13(5):713–22.

    Article  CAS  PubMed  Google Scholar 

  56. Bloom SR, Polak JM. Somatostatin. Br Med J. 1987;295(6593):288–90.

    Article  CAS  Google Scholar 

  57. Korsgren O, Lundgren T, Felldin M, Foss A, Isaksson B, Permert J, et al. Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia. 2008;51(2):227–32.

    Article  CAS  PubMed  Google Scholar 

  58. Shapiro AM. A historical perspective on experimental and clinical islet transplantation. In: Shapiro AM, Shaw JA, editors. Islet transplantation and beta cell replacement therapy. New York, London: Informa Healthcare; 2007.

    Chapter  Google Scholar 

  59. Gabardi S, Martin ST, Roberts KL, Grafals M. Induction immunosuppressive therapies in renal transplantation. Am J Health-System Pharm: AJHP: Official J Am Soc Health-System Pharmacists. 2011;68(3):211–8.

    Article  CAS  Google Scholar 

  60. Hering BJ. Repurification: rescue rather than routine remedy. Am J Transplant. 2005;5(1):1–2.

    Article  PubMed  Google Scholar 

  61. Koh A, Senior P, Salam A, Kin T, Imes S, Dinyari P, et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation. 2010;89(4):465–71.

    Article  CAS  PubMed  Google Scholar 

  62. Matsumoto S, Takita M, Chaussabel D, Noguchi H, Shimoda M, Sugimoto K, et al. Improving efficacy of clinical islet transplantation with iodixanol based islet purification, Thymoglobulin induction and blockage of IL-1-beta and TNF-alpha. Cell Transplant. 2011;20(10):1641–7.

    Google Scholar 

  63. Shapiro AM, Ricordi C. Unraveling the secrets of single donor success in islet transplantation. Am J Transplant. 2004;4(3):295–8.

    Article  PubMed  Google Scholar 

  64. Xenos ES, Farney AC, Widmer MB, Casanova D, Stevens RB, Blazar BR, et al. Effect of tumor necrosis factor alpha and of the soluble tumor necrosis factor receptor on insulin secretion of isolated islets of Langerhans. Transpl Proc. 1992;24(6):2863–4.

    CAS  Google Scholar 

  65. Senior PA, Paty BW, Cockfield SM, Ryan EA, Shapiro AM. Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. Am J Transplant. 2005;5(9):2318–23.

    Article  PubMed  Google Scholar 

  66. Kaplan B, Schold J, Srinivas T, Womer K, Foley DP, Patton P, et al. Effect of sirolimus withdrawal in patients with deteriorating renal function. Am J Transplant. 2004;4(10):1709–12.

    Article  CAS  PubMed  Google Scholar 

  67. The CITR Coordinating Center and Investigators. The collaborative islet transplant registry (CITR) 2011 seventh annual report. https://web.emmes.com/study/isl/reports/01062012_7thAnnualReport.pdf. Accessed 27 Jan 2017.

  68. Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, et al. Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care. 2012;35(7):1436–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Senior PA, Kin T, Shapiro AMJ, Koh A. Islet transplantation at the University of Alberta: status update and review of progress over the last decade. Can J Diabetes. 2012;36:32–7.

    Article  Google Scholar 

  70. Pepper AR, Gala-Lopez B, Ziff O, Shapiro AJ. Current status of clinical islet transplantation. World J Transplant. 2013;3(4):48–53.

    PubMed  PubMed Central  Google Scholar 

  71. Senior PAKT, Shapiro AMJ, Koh A. Islet transplantation at the University of Alberta: Status update and review of progress over the last decade. Can J Diabetes. 2012;36:32–7.

    Article  Google Scholar 

  72. Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA. 2013;310(12):1240–7.

    Article  CAS  PubMed  Google Scholar 

  73. Shapiro AM. Strategies toward single-donor islets of Langerhans transplantation. Curr Opin Organ Transplant. 2011;16(6):627–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Thompson DM, Meloche M, Ao Z, Paty B, Keown P, Shapiro RJ, et al. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation. 2011;91(3):373–8.

    Article  PubMed  Google Scholar 

  75. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes. 2004;53(4):955–62.

    Article  CAS  PubMed  Google Scholar 

  76. Patrick AW, Campbell IW. Fatal hypoglycaemia in insulin-treated diabetes mellitus: clinical features and neuropathological changes. Diabet Med. 1990;7(4):349–54.

    Article  CAS  PubMed  Google Scholar 

  77. Gonder-Frederick LA, Clarke WL, Cox DJ. The Emotional, Social, and Behavioral Implications of Insulin-Induced Hypoglycemia. Semin Clin Neuropsychiatry. 1997;2(1):57–65.

    CAS  PubMed  Google Scholar 

  78. Hathout E, Lakey J, Shapiro J. Islet transplant: an option for childhood diabetes? Arch Dis Child. 2003;88(7):591–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 5-040 Li Ka Shing Health Research, 112 Street and 87 Avenue, Edmonton, AB, T6G 2E1, Canada

    Antonio Bruni & Michael McCall

  2. 2000 College Plaza, 8215 112 Street, Edmonton, AB, T6G 2C8, Canada

    A. M. James Shapiro

Authors
  1. Antonio Bruni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael McCall
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. M. James Shapiro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. M. James Shapiro .

Editor information

Editors and Affiliations

  1. Seattle Children’s Hospital, Seattle, Washington, USA

    Daniel J. Ledbetter

  2. Academic Pediatric Surgery Unit, Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Oxford, United Kingdom

    Paul R.V. Johnson

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Germany

About this chapter

Cite this chapter

Bruni, A., McCall, M., James Shapiro, A.M. (2018). Islet Cell Transplantation. In: Ledbetter, D., Johnson, P. (eds) Endocrine Surgery in Children. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54256-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54256-9_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54254-5

  • Online ISBN: 978-3-662-54256-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation